Skip to main navigation Skip to search Skip to main content

A Multi-center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects with Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event

Project: Research

Project Details

StatusFinished
Effective start/end date11/6/0808/31/12

Funding

  • Schering Plough Research Institute: $118,300.00